文献速递免疫规划传染病防控与疫情报告

华盛顿州金县5-9岁儿童接种5剂无细胞百日咳疫苗后保护持久性研究

Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.
PubMed 文献 · Vaccine · 2021-09-04

该回顾性队列研究纳入美国华盛顿州金县2008-2012年出生、参与州免疫信息系统的5-9岁儿童,评估接种5剂无细胞百日咳疫苗后的时间变化疫苗有效性。队列共55例百日咳病例,其中22例(40%)为完全接种、33例(60%)为接种不足;生存分析显示第五剂后42个月内疫苗有效性为89%(95%CI:64%,97%),泊松回归显示4年内为93%(95%CI:67%,98%)。结论为未发现5剂后4年内疫苗有效性减弱的证据。

要点

  • 5剂无细胞百日咳疫苗后42个月内疫苗有效性为89%(95%CI:64%,97%)。
  • 泊松回归估计4年内疫苗有效性为93%(95%CI:67%,98%)。
  • 研究未发现5-9岁儿童接种5剂后4年内疫苗有效性减弱的证据。

核心结论

  • 在华盛顿州金县5-9岁儿童中,未发现接种5剂无细胞百日咳疫苗后4年内疫苗有效性减弱的证据。

研究设计与样本

  • 回顾性队列研究,对象为美国华盛顿州金县2008-2012年出生、参与华盛顿州免疫信息系统的5-9岁儿童。
  • 采用Cox比例风险模型平滑缩放Schoenfeld残差和分段常数泊松回归估计时间变化疫苗有效性。

主要发现

  • 队列共55例百日咳病例,其中22例(40%)为完全接种,33例(60%)为接种不足。
  • 生存分析方法估计第五剂后42个月内疫苗有效性为89%(95%CI:64%,97%)。
  • 泊松回归估计第五剂后4年内疫苗有效性为93%(95%CI:67%,98%)。

临床怎么用

  • 在5-9岁儿童中,接种5剂无细胞百日咳疫苗后4年内仍可维持较高保护水平,支持按程序完成5剂接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Waning of immunity after vaccination with the acellular Pertussis (aP) vaccine has been proposed as one of the main reasons for pertussis resurgence in the US. In this study, we estimated time-varying vaccine effectiveness after 5 doses of aP vaccine. METHODS: We conducted a retrospective cohort study among children 5-9 years old (born between 2008 and 2012) living in King County, Washington, USA, who participated in the Washington State Immunization Information System. We estimated time-varying vaccine effectiveness after 5 doses of aP using smoothed scaled Schoenfeld residuals obtained from fitting Cox proportional hazards models to the data as well as piecewise constant Poisson regression. RESULTS: There were 55 pertussis cases in this cohort, of whom 22 (40%) were fully-vaccinated and 33 (60%) were under-vaccinated. Vaccine effectiveness (VE) remained high for up to 42 months after the fifth dose (VE(t) = 89%; 95% CI: 64%, 97%) as estimated using survival analysis methods and up to 4 years (VE(t) = 93%; 95% CI: 67%, 98%) as estimated using Poisson regression. CONCLUSION: We did not find evidence for waning of vaccine effectiveness for up to four years after 5 doses of aP among 5 -9 years old children in King County, WA.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rane MS, Rohani P, Halloran ME, et al. Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington. Vaccine. 2021. PMID: 34493409. doi:10.1016/j.vaccine.2021.08.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。